The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more ...

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

The human genome encodes potentially thousands of tiny proteins that were previously overlooked. The search is on to find out ...

The CRISPR-Cas9 platform will be used to delete the PD-1 gene in T cells extracted from trial participant’s blood. In healthy cells, an activated PD-1 gene results in the production of the PD-1 ...

The idea behind the notorious CRISPR-baby scandal, editing reproductive cells or embryos tinkers with DNA far beyond ... the disgraced scientist first to experiment with editing human embryos, to jail ...

"As CRISPR therapies enter the clinic ... by these predictions and tested the most promising candidates in human cells and in mice that were genetically modified to bear key components of the ...

And in December, it shelved a sickle cell treatment similar to Casgevy, the treatment approved in late 2023 from Vertex and CRISPR Therapeutics. Casgevy’s slow rollout — it appears to have ...

In December 2023, the FDA approved the first Crispr-based therapy for sickle cell disease ... of mice that have been engineered to carry the human progeria mutation. Our team is now working ...

Editas and CRISPR are probably most closely linked as they both pursued Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT) early on. Despite this similarity, the two ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We've got lots ...